Methylparaben in skincare
Methylparaben is one of the oldest and best-studied preservatives, protecting cosmetics from bacteria and mould. In 2023 the SCCS concluded it is safe at up to 0.4%, after considering the data on hormonal activity. Frankly flags it as a potential endocrine disruptor because some rodent studies found oestrogen-like effects and France's ANSES concluded in 2025 that it is an endocrine disruptor, although the studies do not all agree. It can also irritate or sensitise, especially damaged skin.
Also known as: methyl paraben, E218
Frankly rating by skin type
Dry skin with a weakened barrier irritates more easily, and the potential endocrine disruptor flag comes on top. If you would rather avoid it, pick a cream with a different preservative.
It does nothing to oil or pores. The cautious rating comes from the potential endocrine disruptor flag and possible irritation.
For combination skin the endocrine flag is what counts, even though the SCCS considers up to 0.4% safe. Whether you limit such ingredients is your call.
This is where caution matters most: on top of the endocrine flag there is a risk of irritation and allergy, especially on broken or eczema-prone skin. Avoid it if you have a known paraben allergy.
It does not clog pores, so it does not encourage blackheads. The cautious rating comes from the endocrine flag and possible irritation.
Redness-prone skin reacts to irritants more readily, and the endocrine flag adds to that. Patch test a new paraben product on a small area first.
This is how the Frankly app rates this ingredient for each skin type. Beneficial means it helps that skin, Neutral that it has no particular benefit or drawback for it, Trade-offs that it has both, and Caution that it may irritate or harm it. In the app the rating also weighs your concerns and sensitivities.
What methylparaben is
Methylparaben is the methyl ester of p-hydroxybenzoic acid. Parabens have been used as preservatives in cosmetics, medicines and food since the 1920s. Methylparaben has the shortest chain in the group and the weakest hormonal activity of the parabens. It is often combined with other preservatives to protect a product against a wider range of microbes.
Parabens and hormones: what the evidence says
The concern about parabens is their weak, oestrogen-like activity in laboratory tests. In opinion SCCS/1652/23 (December 2023), the EU Scientific Committee on Consumer Safety reviewed the data, including the potential endocrine effects, and concluded that methylparaben is safe at up to 0.4% in a product, and up to 0.8% in total with other parabens of the same group.
Frankly flags methylparaben as a potential endocrine disruptor on the animal evidence, which is mixed. Given by mouth to young rats at 20 mg/kg body weight a day, it made the uterus grow, a typical oestrogen effect (Sun 2016), as it did when injected into mice and rats (Lemini 2003), and at 1000 mg/kg a day it delayed puberty and changed the ovaries (Vo 2010). Other studies found no uterus growth in mice (Hossaini 2000) and no effect on the male rat reproductive system (Hoberman 2008).
On 15 April 2025 France's ANSES concluded that methylparaben is an endocrine disruptor for human health and the environment, and on 21 May 2026 France registered its intention to propose a harmonised EU classification. The European Chemicals Agency's Committee for Risk Assessment (RAC) has not yet given an opinion. The SCCS limits are about dose: they set how much can safely be used in a cosmetic, but they do not change the assessment of its hormonal potential.
Irritation and allergy
Paraben allergy is rare on healthy skin. Sensitisation has mostly occurred when paraben-containing products were applied to damaged skin, for example leg ulcers, which is known as the paraben paradox. Frankly counts it as a possible allergen and irritant, which weighs most on the verdict for sensitive skin.
EU rules
Methylparaben is an authorised preservative in Annex V (entry 12) of Regulation (EC) No 1223/2009: at most 0.4% (as acid) for a single ester and 0.8% for mixtures of esters. The SCCS confirmed these levels as safe in opinion SCCS/1652/23 (2023).